Key result
RSV prefusion F vaccine reduces RSV-related respiratory hospitalizations in older adults vs no vaccine.
Why the study?
Does RSV prefusion F vaccine reduce hospitalization for RSV-related respiratory tract disease in older adults?
Does RSV prefusion F vaccine reduce hospitalization for RSV-related respiratory tract disease in older adults?
In older adults, the RSV prefusion F vaccine reduces hospitalizations for RSV-related respiratory tract disease compared to no vaccine.
Answers are grounded in this paper and cite their sources.
May support RSV prefusion F vaccination in older adults; leaves open translation from animal models.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sacks et al. (2026) studied this question. The RSV prefusion F vaccine reduced hospitalization for RSV-related respiratory tract disease in older adults compared to no vaccine.
Synapse has enriched 10 related papers. Consider them for comparative context: